250 related articles for article (PubMed ID: 11350180)
1. Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry.
Whitfield PD; Sharp PC; Johnson DW; Nelson P; Meikle PJ
Mol Genet Metab; 2001 May; 73(1):30-7. PubMed ID: 11350180
[TBL] [Abstract][Full Text] [Related]
2. Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.
Kuchař L; Asfaw B; Poupětová H; Honzíková J; Tureček F; Ledvinová J
Clin Chim Acta; 2013 Oct; 425():153-9. PubMed ID: 23838369
[TBL] [Abstract][Full Text] [Related]
3. An unusual homozygous arylsulfatase: a pseudodeficiency in a metachromatic leukodystrophy Tunisian patient.
Tinsa F; Caillaud C; Vanier MT; Bousnina D; Boussetta K; Bousnina S
J Child Neurol; 2010 Jan; 25(1):82-6. PubMed ID: 19574581
[TBL] [Abstract][Full Text] [Related]
4. Biochemical profiling to predict disease severity in metachromatic leukodystrophy.
Tan MA; Fuller M; Zabidi-Hussin ZA; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2010 Feb; 99(2):142-8. PubMed ID: 19815439
[TBL] [Abstract][Full Text] [Related]
5. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity.
Molzer B; Sundt-Heller R; Kainz-Korschinsky M; Zobel M
Am J Med Genet; 1992 Nov; 44(4):523-6. PubMed ID: 1359786
[TBL] [Abstract][Full Text] [Related]
6. Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies.
Cui Y; Colsch B; Afonso C; Baumann N; Tabet JC; Mallet JM; Zhang Y
Glycoconj J; 2008 Feb; 25(2):147-55. PubMed ID: 17701343
[TBL] [Abstract][Full Text] [Related]
7. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy.
Han M; Jun SH; Song SH; Park HD; Park KU; Song J
Rapid Commun Mass Spectrom; 2014 Mar; 28(6):587-94. PubMed ID: 24519821
[TBL] [Abstract][Full Text] [Related]
8. Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies.
Berná L; Asfaw B; Conzelmann E; Cerný B; Ledvinová J
Anal Biochem; 1999 May; 269(2):304-11. PubMed ID: 10222002
[TBL] [Abstract][Full Text] [Related]
9. Quantification of plasma sulfatides by mass spectrometry: Utility for metachromatic leukodystrophy.
Saville JT; Smith NJ; Fletcher JM; Fuller M
Anal Chim Acta; 2017 Feb; 955():79-85. PubMed ID: 28088283
[TBL] [Abstract][Full Text] [Related]
10. Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples.
Spacil Z; Babu Kumar A; Liao HC; Auray-Blais C; Stark S; Suhr TR; Scott CR; Turecek F; Gelb MH
Clin Chem; 2016 Jan; 62(1):279-86. PubMed ID: 26585924
[TBL] [Abstract][Full Text] [Related]
11. Urine sulfatides and the diagnosis of metachromatic leukodystrophy.
Natowicz MR; Prence EM; Chaturvedi P; Newburg DS
Clin Chem; 1996 Feb; 42(2):232-8. PubMed ID: 8595716
[TBL] [Abstract][Full Text] [Related]
12. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
13. Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry.
Barcenas M; Suhr TR; Scott CR; Turecek F; Gelb MH
Clin Chim Acta; 2014 Jun; 433():39-43. PubMed ID: 24370383
[TBL] [Abstract][Full Text] [Related]
14. Metachromatic leukodystrophy: clinical and enzymatic parameters.
McKhann GM
Neuropediatrics; 1984 Sep; 15 Suppl():4-10. PubMed ID: 6152812
[TBL] [Abstract][Full Text] [Related]
15. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry.
Mirzaian M; Kramer G; Poorthuis BJ
J Lipid Res; 2015 Apr; 56(4):936-43. PubMed ID: 25632048
[TBL] [Abstract][Full Text] [Related]
16. Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.
Harzer K; Recke AS
Humangenetik; 1975 Oct; 29(4):299-307. PubMed ID: 1176145
[TBL] [Abstract][Full Text] [Related]
17. HPLC analysis of urinary sulfatide: an aid in the diagnosis of metachromatic leukodystrophy.
Strasberg PM; Warren I; Skomorowski MA; Lowden JA
Clin Biochem; 1985 Apr; 18(2):92-7. PubMed ID: 2861921
[TBL] [Abstract][Full Text] [Related]
18. Human urinary sulfatides in patients with sulfatidosis (metachromatic leukodystrophy).
Philippart M; Sarlieve L; Meurant C; Mechler L
J Lipid Res; 1971 Jul; 12(4):434-41. PubMed ID: 5164093
[TBL] [Abstract][Full Text] [Related]
19. Marked clinical difference between two sibs affected with juvenile metachromatic leukodystrophy.
Clarke JT; Skomorowski MA; Chang PL
Am J Med Genet; 1989 May; 33(1):10-3. PubMed ID: 2568751
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology of sulfatide metabolism in metachromatic leukodystrophy].
Wiesmann UN
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):33-47. PubMed ID: 27269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
